Cytokinetics (CYTK) Q2 2024 Earnings

May 8Confirmed
Q3 2023
Q4 2023
Q1 2024
Q2 2024
-1.38
-1.17
-0.97
-0.76

Details

Expected EPS
-1.143663
Actual EPS
-1.33
Surprise EPS
-0.19
Surprise Percent
-16.29%

Description

⁨Cytokinetics⁩ (⁦CYTK⁩) has reported earnings of ⁦-1.33⁩ per share for ⁦Q2 2024⁩.

0 Comments

Share your thoughts